Sage ( DrugBank: Sage )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	5

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05318937 (ClinicalTrials.gov)	July 6, 2022	1/4/2022	A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impai ...	A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Parkinso ...	Parkinson Disease;Cognitive Dysfunction	Drug: SAGE-718;Drug: SAGE-718-matching placebo	Sage Therapeutics	NULL	Recruiting	50 Years	75 Years	All	76	Phase 2	United States
2	NCT04476017 (ClinicalTrials.gov)	September 11, 2020	15/7/2020	A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease ...	An Open-Label Evaluation of the Safety and Tolerability of SAGE-718 in Participants With Parkinson's ...	Parkinson Disease;Cognitive Dysfunction	Drug: SAGE-718	Sage Therapeutics	NULL	Completed	50 Years	75 Years	All	18	Phase 2	United States
3	NCT03000569 (ClinicalTrials.gov)	November 30, 2016	28/11/2016	A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease	A Phase 2, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SA ...	Parkinson Disease	Drug: SAGE-217;Drug: Levodopa;Drug: Antiparkinsonian Agent(s)	Sage Therapeutics	NULL	Completed	40 Years	75 Years	All	29	Phase 2	United States
4	NCT02225548 (ClinicalTrials.gov)	September 2014	22/8/2014	Sagene 2014 - Parkinson's Disease and Erectile Dysfunction	An Open-label Trial of Oral Selegiline 5 or 10 mg and Tadalafil 2.5mg Co-administration to Male Pati ...	Parkinson's Disease;Erectile Dysfunction	Drug: Selegiline;Drug: Tadalafil	University of South Florida	NULL	Recruiting	40 Years	64 Years	Male	10	Phase 4	United States
5	EUCTR2007-002899-34-GB (EUCTR)	18/09/2007	26/06/2007	Pilot Controlled Clinical Trial of Salvia Officinalis (Sage) for cognitive impairments in Parkinson' ...	Pilot Controlled Clinical Trial of Salvia Officinalis (Sage) for cognitive impairments in Parkinson' ...	Cognitive impairment in Parkinson's Disease	Product Name: Sage leaf	Newcastle Upon tyne Hospitals NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes			United Kingdom

First Previous1Next Last